A diagnostic assay for the detection of SARS-CoV-2, the virus responsible for COVID-19. This assay is part of the Allplex™ product line for respiratory infection testing.
Manufactured by
South Korea
Seegene is a South Korean biotechnology company founded in 2000, specializes in the development, manufacturing, and global distribution of molecular diagnostic (MDx) products, especially in vitro diagnostics (IVD) based on PCR technology. Currently, our product portfolio consists of over 250 molecular diagnostic assays.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
KogeneBiotech Co., Ltd.
South Korea · 2 relevant products
Applied Biocode, Inc.
United States · 3 relevant products
APPOLON BIOTECK SAS
France · 2 relevant products
Credo Diagnostics Biomedical Pte. Ltd.
Singapore · 4 relevant products
Hangzhou AllTest Biotech Co.,Ltd
China · 3 relevant products
DIA.PRO Diagnostic BioProbes Srl
Italy · 3 relevant products
CALTH Inc.
South Korea · 5 relevant products
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 2 relevant products
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 1 relevant product
67 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 108 closest product alternatives
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for SARS-CoV-2 detection with high sensitivity and specificity. Delivers reliable results for COVID-19 diagnosis in clinical and point-of-care settings.
KogeneBiotech Co., Ltd. · South Korea
Multiplex real-time PCR assay enabling simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B from a single sample. This molecular diagnostic test provides efficient multi-pathogen screening in clinical settings.
Applied Biocode, Inc. · United States
A clinical diagnostic assay for simultaneous detection of SARS-CoV-2 and influenza pathogens. This multiplex testing product incorporates Applied Biocode's Barcoded Magnetic Bead (BMB) technology for comprehensive respiratory pathogen identification.
APPOLON BIOTECK SAS · France
Multiplex RT-PCR kit for detection of major respiratory viral infections including SARS-CoV-2, influenza, and respiratory syncytial virus. This test enables simultaneous identification of multiple clinically significant respiratory viruses.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A rapid diagnostic test for detecting SARS-CoV-2 and future variants at the point of care. Plays a crucial role in infection control and prevention of viral spread.
Applied Biocode, Inc. · United States
Multiplex molecular diagnostic assay for simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B. Enables comprehensive respiratory pathogen screening in single test format.
Hangzhou AllTest Biotech Co.,Ltd · China
A real-time quantitative PCR assay for the detection and quantification of SARS-CoV-2 in human samples.
Applied Biocode, Inc. · United States
Molecular diagnostic assay for detection of SARS-CoV-2. FDA-cleared in vitro diagnostic test providing reliable identification of COVID-19 infection.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A multiplex real-time PCR assay for the VitaPCR™ platform that simultaneously detects Influenza and SARS-CoV-2 from patient samples.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A rapid and accurate diagnostic test for simultaneous detection of influenza and COVID-19 at the point of care. Enables differentiation between respiratory pathogens in 20 minutes.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
Rapid molecular diagnostic assay for simultaneous detection of SARS-CoV-2, influenza, and RSV. Delivers real-time PCR results in 20 minutes from sample collection, enabling point-of-care testing and immediate clinical decision-making. Designed for deployment in clinical settings to reduce turnaround time and diagnostic costs.
DIA.PRO Diagnostic BioProbes Srl · Italy
A CLIA-based diagnostic test for the detection of COVID-19. This assay is designed for clinical laboratory analysis of SARS-CoV-2 infection.
96 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products